1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Stream Infection Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39E5913
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Blood Stream Infection Testing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Blood Stream Infection Testing Market Research Report 2025

Code: QYRE-Auto-39E5913
Report
September 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Stream Infection Testing Market Size

The global market for Blood Stream Infection Testing was valued at US$ 4192 million in the year 2024 and is projected to reach a revised size of US$ 6603 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Blood Stream Infection Testing Market

Blood Stream Infection Testing Market

BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Stream Infection Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Stream Infection Testing.
The Blood Stream Infection Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Stream Infection Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Stream Infection Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Blood Stream Infection Testing Market Report

Report Metric Details
Report Name Blood Stream Infection Testing Market
Accounted market size in year US$ 4192 million
Forecasted market size in 2031 US$ 6603 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Conventional Blood Culture Tests
  • PCR Methods
  • Nucleic Acid Testing
  • Mass Spectroscopy
  • Point of Care Testing
Segment by Application
  • Hospitals
  • Independent Diagnostic Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, bioMérieux, Cepheid, Roche Diagnostics, IRIDICA, Bruker, Nanosphere, Siemens, AdvanDX
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Blood Stream Infection Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Stream Infection Testing Market growing?

Ans: The Blood Stream Infection Testing Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Blood Stream Infection Testing Market size in 2031?

Ans: The Blood Stream Infection Testing Market size in 2031 will be US$ 6603 million.

Who are the main players in the Blood Stream Infection Testing Market report?

Ans: The main players in the Blood Stream Infection Testing Market are BD, bioMérieux, Cepheid, Roche Diagnostics, IRIDICA, Bruker, Nanosphere, Siemens, AdvanDX

What are the Application segmentation covered in the Blood Stream Infection Testing Market report?

Ans: The Applications covered in the Blood Stream Infection Testing Market report are Hospitals, Independent Diagnostic Centers, Others

What are the Type segmentation covered in the Blood Stream Infection Testing Market report?

Ans: The Types covered in the Blood Stream Infection Testing Market report are Conventional Blood Culture Tests, PCR Methods, Nucleic Acid Testing, Mass Spectroscopy, Point of Care Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Stream Infection Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Conventional Blood Culture Tests
1.2.3 PCR Methods
1.2.4 Nucleic Acid Testing
1.2.5 Mass Spectroscopy
1.2.6 Point of Care Testing
1.3 Market by Application
1.3.1 Global Blood Stream Infection Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Independent Diagnostic Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Stream Infection Testing Market Perspective (2020-2031)
2.2 Global Blood Stream Infection Testing Growth Trends by Region
2.2.1 Global Blood Stream Infection Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Blood Stream Infection Testing Historic Market Size by Region (2020-2025)
2.2.3 Blood Stream Infection Testing Forecasted Market Size by Region (2026-2031)
2.3 Blood Stream Infection Testing Market Dynamics
2.3.1 Blood Stream Infection Testing Industry Trends
2.3.2 Blood Stream Infection Testing Market Drivers
2.3.3 Blood Stream Infection Testing Market Challenges
2.3.4 Blood Stream Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Stream Infection Testing Players by Revenue
3.1.1 Global Top Blood Stream Infection Testing Players by Revenue (2020-2025)
3.1.2 Global Blood Stream Infection Testing Revenue Market Share by Players (2020-2025)
3.2 Global Blood Stream Infection Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Blood Stream Infection Testing Revenue
3.4 Global Blood Stream Infection Testing Market Concentration Ratio
3.4.1 Global Blood Stream Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Stream Infection Testing Revenue in 2024
3.5 Global Key Players of Blood Stream Infection Testing Head office and Area Served
3.6 Global Key Players of Blood Stream Infection Testing, Product and Application
3.7 Global Key Players of Blood Stream Infection Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Stream Infection Testing Breakdown Data by Type
4.1 Global Blood Stream Infection Testing Historic Market Size by Type (2020-2025)
4.2 Global Blood Stream Infection Testing Forecasted Market Size by Type (2026-2031)
5 Blood Stream Infection Testing Breakdown Data by Application
5.1 Global Blood Stream Infection Testing Historic Market Size by Application (2020-2025)
5.2 Global Blood Stream Infection Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Blood Stream Infection Testing Market Size (2020-2031)
6.2 North America Blood Stream Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Blood Stream Infection Testing Market Size by Country (2020-2025)
6.4 North America Blood Stream Infection Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Stream Infection Testing Market Size (2020-2031)
7.2 Europe Blood Stream Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Blood Stream Infection Testing Market Size by Country (2020-2025)
7.4 Europe Blood Stream Infection Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Stream Infection Testing Market Size (2020-2031)
8.2 Asia-Pacific Blood Stream Infection Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Stream Infection Testing Market Size (2020-2031)
9.2 Latin America Blood Stream Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Blood Stream Infection Testing Market Size by Country (2020-2025)
9.4 Latin America Blood Stream Infection Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Stream Infection Testing Market Size (2020-2031)
10.2 Middle East & Africa Blood Stream Infection Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Blood Stream Infection Testing Introduction
11.1.4 BD Revenue in Blood Stream Infection Testing Business (2020-2025)
11.1.5 BD Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Details
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Blood Stream Infection Testing Introduction
11.2.4 bioMérieux Revenue in Blood Stream Infection Testing Business (2020-2025)
11.2.5 bioMérieux Recent Development
11.3 Cepheid
11.3.1 Cepheid Company Details
11.3.2 Cepheid Business Overview
11.3.3 Cepheid Blood Stream Infection Testing Introduction
11.3.4 Cepheid Revenue in Blood Stream Infection Testing Business (2020-2025)
11.3.5 Cepheid Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Blood Stream Infection Testing Introduction
11.4.4 Roche Diagnostics Revenue in Blood Stream Infection Testing Business (2020-2025)
11.4.5 Roche Diagnostics Recent Development
11.5 IRIDICA
11.5.1 IRIDICA Company Details
11.5.2 IRIDICA Business Overview
11.5.3 IRIDICA Blood Stream Infection Testing Introduction
11.5.4 IRIDICA Revenue in Blood Stream Infection Testing Business (2020-2025)
11.5.5 IRIDICA Recent Development
11.6 Bruker
11.6.1 Bruker Company Details
11.6.2 Bruker Business Overview
11.6.3 Bruker Blood Stream Infection Testing Introduction
11.6.4 Bruker Revenue in Blood Stream Infection Testing Business (2020-2025)
11.6.5 Bruker Recent Development
11.7 Nanosphere
11.7.1 Nanosphere Company Details
11.7.2 Nanosphere Business Overview
11.7.3 Nanosphere Blood Stream Infection Testing Introduction
11.7.4 Nanosphere Revenue in Blood Stream Infection Testing Business (2020-2025)
11.7.5 Nanosphere Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Blood Stream Infection Testing Introduction
11.8.4 Siemens Revenue in Blood Stream Infection Testing Business (2020-2025)
11.8.5 Siemens Recent Development
11.9 AdvanDX
11.9.1 AdvanDX Company Details
11.9.2 AdvanDX Business Overview
11.9.3 AdvanDX Blood Stream Infection Testing Introduction
11.9.4 AdvanDX Revenue in Blood Stream Infection Testing Business (2020-2025)
11.9.5 AdvanDX Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Blood Stream Infection Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Conventional Blood Culture Tests
 Table 3. Key Players of PCR Methods
 Table 4. Key Players of Nucleic Acid Testing
 Table 5. Key Players of Mass Spectroscopy
 Table 6. Key Players of Point of Care Testing
 Table 7. Global Blood Stream Infection Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Blood Stream Infection Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Blood Stream Infection Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Blood Stream Infection Testing Market Share by Region (2020-2025)
 Table 11. Global Blood Stream Infection Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Blood Stream Infection Testing Market Share by Region (2026-2031)
 Table 13. Blood Stream Infection Testing Market Trends
 Table 14. Blood Stream Infection Testing Market Drivers
 Table 15. Blood Stream Infection Testing Market Challenges
 Table 16. Blood Stream Infection Testing Market Restraints
 Table 17. Global Blood Stream Infection Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Blood Stream Infection Testing Market Share by Players (2020-2025)
 Table 19. Global Top Blood Stream Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Stream Infection Testing as of 2024)
 Table 20. Ranking of Global Top Blood Stream Infection Testing Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Blood Stream Infection Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Blood Stream Infection Testing, Headquarters and Area Served
 Table 23. Global Key Players of Blood Stream Infection Testing, Product and Application
 Table 24. Global Key Players of Blood Stream Infection Testing, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Blood Stream Infection Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Blood Stream Infection Testing Revenue Market Share by Type (2020-2025)
 Table 28. Global Blood Stream Infection Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Blood Stream Infection Testing Revenue Market Share by Type (2026-2031)
 Table 30. Global Blood Stream Infection Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Blood Stream Infection Testing Revenue Market Share by Application (2020-2025)
 Table 32. Global Blood Stream Infection Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Blood Stream Infection Testing Revenue Market Share by Application (2026-2031)
 Table 34. North America Blood Stream Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Blood Stream Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Blood Stream Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Blood Stream Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Blood Stream Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Blood Stream Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Blood Stream Infection Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Blood Stream Infection Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Blood Stream Infection Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Blood Stream Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Blood Stream Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Blood Stream Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Blood Stream Infection Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Blood Stream Infection Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Blood Stream Infection Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 49. BD Company Details
 Table 50. BD Business Overview
 Table 51. BD Blood Stream Infection Testing Product
 Table 52. BD Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 53. BD Recent Development
 Table 54. bioMérieux Company Details
 Table 55. bioMérieux Business Overview
 Table 56. bioMérieux Blood Stream Infection Testing Product
 Table 57. bioMérieux Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 58. bioMérieux Recent Development
 Table 59. Cepheid Company Details
 Table 60. Cepheid Business Overview
 Table 61. Cepheid Blood Stream Infection Testing Product
 Table 62. Cepheid Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 63. Cepheid Recent Development
 Table 64. Roche Diagnostics Company Details
 Table 65. Roche Diagnostics Business Overview
 Table 66. Roche Diagnostics Blood Stream Infection Testing Product
 Table 67. Roche Diagnostics Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 68. Roche Diagnostics Recent Development
 Table 69. IRIDICA Company Details
 Table 70. IRIDICA Business Overview
 Table 71. IRIDICA Blood Stream Infection Testing Product
 Table 72. IRIDICA Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 73. IRIDICA Recent Development
 Table 74. Bruker Company Details
 Table 75. Bruker Business Overview
 Table 76. Bruker Blood Stream Infection Testing Product
 Table 77. Bruker Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 78. Bruker Recent Development
 Table 79. Nanosphere Company Details
 Table 80. Nanosphere Business Overview
 Table 81. Nanosphere Blood Stream Infection Testing Product
 Table 82. Nanosphere Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 83. Nanosphere Recent Development
 Table 84. Siemens Company Details
 Table 85. Siemens Business Overview
 Table 86. Siemens Blood Stream Infection Testing Product
 Table 87. Siemens Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 88. Siemens Recent Development
 Table 89. AdvanDX Company Details
 Table 90. AdvanDX Business Overview
 Table 91. AdvanDX Blood Stream Infection Testing Product
 Table 92. AdvanDX Revenue in Blood Stream Infection Testing Business (2020-2025) & (US$ Million)
 Table 93. AdvanDX Recent Development
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources
 Table 97. Authors List of This Report


List of Figures
 Figure 1. Blood Stream Infection Testing Picture
 Figure 2. Global Blood Stream Infection Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blood Stream Infection Testing Market Share by Type: 2024 VS 2031
 Figure 4. Conventional Blood Culture Tests Features
 Figure 5. PCR Methods Features
 Figure 6. Nucleic Acid Testing Features
 Figure 7. Mass Spectroscopy Features
 Figure 8. Point of Care Testing Features
 Figure 9. Global Blood Stream Infection Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Blood Stream Infection Testing Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Independent Diagnostic Centers Case Studies
 Figure 13. Others Case Studies
 Figure 14. Blood Stream Infection Testing Report Years Considered
 Figure 15. Global Blood Stream Infection Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Blood Stream Infection Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Blood Stream Infection Testing Market Share by Region: 2024 VS 2031
 Figure 18. Global Blood Stream Infection Testing Market Share by Players in 2024
 Figure 19. Global Top Blood Stream Infection Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Stream Infection Testing as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Blood Stream Infection Testing Revenue in 2024
 Figure 21. North America Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Blood Stream Infection Testing Market Share by Country (2020-2031)
 Figure 23. United States Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Blood Stream Infection Testing Market Share by Country (2020-2031)
 Figure 27. Germany Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Blood Stream Infection Testing Market Share by Region (2020-2031)
 Figure 35. China Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Blood Stream Infection Testing Market Share by Country (2020-2031)
 Figure 43. Mexico Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Blood Stream Infection Testing Market Share by Country (2020-2031)
 Figure 47. Turkey Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Blood Stream Infection Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. BD Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 51. bioMérieux Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 52. Cepheid Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 53. Roche Diagnostics Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 54. IRIDICA Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 55. Bruker Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 56. Nanosphere Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 57. Siemens Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 58. AdvanDX Revenue Growth Rate in Blood Stream Infection Testing Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS